Postrelapse survival in osteosarcoma of the extremities: Prognostic factors for long-term survival

Journal of Clinical Oncology

Volumn 21, Issue 4, 2003, Pages 710-715

  Ferrari, Stefano ^a   Briccoli, Antonio ^a   Mercuri, Mario ^a   Bertoni, Franco ^a   Picci, Piero ^a   Tienghi, Amelia ^a   Del Prever, Adalberto Brach ^a   Fagioli, Franca ^a   Comandone, Alessandro ^a   Bacci, Gaetano ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; DISEASE FREE INTERVAL; DRUG MEGADOSE; HUMAN; LIMB TUMOR; LUNG METASTASIS; LUNG NODULE; OSTEOSARCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL TIME; ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; CHILD; CONFIDENCE INTERVAL; LUNG TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0037441937     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.03.141     Document Type: Review

References (25)

1. Campanacci M: Bone and Soft Tissue Tumors. New York, NY, Springer-Verlag, 1999, pp 463-557
2. Bramwell VHC, Burgers M, Sneath R, et al: A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup. J Clin Oncol 10:1579-1591, 1992
3. Bacci G, Picci P, Ferrari S, et al: Primary chemotherapy and delayed surgery for non metastatic osteosarcoma of the extremity: Results in 164 patients preoperatively treated with high doses of methotrexate, followed by cisplatin and doxorubicin. Cancer 72:1216-1226, 1993
4. Provisor AJ, Ettiger LJ, Nachman JB, et al: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group. J Clin Oncol 15:76-84, 1997
5. Meyers PA, Gorlick R, Heller G, et al: Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the Memorial Sloan-Kettering (T-12) protocol. J Clin Oncol 16:2452-2458, 1998
6. Fuchs N, Bielack S, Epler D, et al: Long-term results of the cooperative German-Austrian-Swiss Osteosarcoma Study Group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893-899, 1998
7. Putnam JB, Roth JA, Wesley MN, et al: Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: Analysis of prognostic factors. Ann Thorac Surg 36:516-523, 1983
8. Goorin AM, Delorey MJ, Lack EE, et al: Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: Analysis of 32 patients. J Clin Oncol 2:425-431, 1984
9. Beron G, Euler A, Winkler K: Pulmonary metastases from osteogenic sarcoma: Complete resection and effective chemotherapy contributing to improved prognosis. Eur Paediatr Haematol Oncol 2:77-85, 1985
10. Meyer WH, Schell MJ, Kumar AP, et al: Thoracotomy for pulmonary metastatic osteosarcoma: An analysis of prognostic indicators of survival. Cancer 59:374-379, 1987
11. Huth JF, Eilber FR: Patterns of recurrence after resection of osteosarcoma of the extremity: Strategies for treatment of metastases. Arch Surg 124:122-126, 1989
12. Belli L, Scholl S, Livartowski A, et al: Resection of pulmonary metastases in osteosarcoma: A retrospective analysis of 44 patients. Cancer 63:2546-2550, 1989
13. Skinner KA, Eilber FR, Holmes EC, et al: Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma. Arch Surg 127:1065-1071, 1992
14. Ward WG, Mikaelian K, Dorey F, et al: Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 12:1849-1858, 1994
15. Saeter G, Hoie J, Stenwig AE, et al: Systemic relapse of patients with osteogenic sarcoma: Prognostic factors for long term survival. Cancer 75:1084-1093, 1995
16. Antunes M, Bernardo J, Salete M, et al: Excision of pulmonary metastases of osteogenic sarcoma of limbs. Eur J Cardiothorac Surg 15:592-598, 1999
17. Goorin AM, Shuster JJ, Baker A, et al: Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: Results from the multi-institutional osteosarcoma study. J Clin Oncol 9:600-605, 1991
18. Ferrari S, Mercuri M, Picci P, et al: Results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response. Tumori 85:458-464, 1999
19. Bacci G, Ferrari S, Mercuri M, et al: Neoadjuvant chemotherapy for extremity osteosarcoma: Preliminary results of the Rizzoli's 4th study. Acta Oncol 37:41-48, 1998
20. Bacci G, Ferrari S, Longhi A, et al: Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: Long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemother 13:93-99, 2001
21. Bacci G, Ferrari S, Mercuri M, et al: Predictive factors for local recurrence in osteosarcoma. Acta Orthop Scand 69:230-236, 1998
22. Weeden S, Grimer RJ, Cannon SR, et al: The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer 37:39-46, 2001
23. Pastorino U, Buyse M, Friedel G, et al: Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 113:37-49, 1997
24. Daw N, Rodriguez-Galindo C, Rao B, et al: Outcome of patients presenting with a single pulmonary metastasis more than one year after diagnosis of osteosarcoma. Proc Am Soc Clin Oncol 19:596, 2000 (abstr 2345)
25. Patel SR, Vadhan-Raj S, Papadopulos N, et al: High-dose ifosfamide in bone and soft tissue sarcomas: Results of phase II and pilot studies-dose response and schedule dependence. J Clin Oncol 15:2378-2384, 1997